Archives for October 2022

Ontario Genomics Partners with The Cultivated B. to Drive Growth of Ontario’s Cellular Agriculture Industry

October 27, 2022, BurlingtonThe Cultivated B. announce an expansion in cellular agriculture operations to Canada, opening their 130,000-square-foot manufacturing facility and innovation hub in Burlington, Ontario, Canada. Ontario Genomics is partnering on the creation of this innovation hub to build on the momentum of this budding cellular agriculture ecosystem. The Cultivated B. (TCB) is a bioengineering company that provides access to plant-based and cell-based alternative protein sources and plans to hire over 200 employees at the new facility in the coming years. The facility will develop and produce bioreactors from 500 ml to 25,000 liters, photobioreactors and high-precision devices for cellular agriculture and precision fermentation. This will enable other businesses to produce alternative proteins at an industrial scale, whether in the cultivated meat, ingredients, pharmaceutical, or cosmetic industries. The facility will further house PreFer Industries, a subsidiary of The Cultivated B., focusing on developing alternative, particularly plant-based protein sources through precision fermentation.

Earlier this month at Toronto Global, TCB and Ontario Genomics signed a memorandum of understanding to drive forward a shared vision of developing the cellular agriculture ecosystem within Ontario and Canada, and offering opportunities to companies within the cellular agriculture and biotechnology industries. This strategic partnership will see approximately 20,000 square foot of the building dedicated to growing an innovation hub, providing small and mid-size cellular agriculture and other biotechnology companies with access to laboratory space, bioreactors and mentorship to test and scale up their products. Enabling access to this necessary and specialized infrastructure will help shape the landscape of the cellular agriculture industry within Canada and drive forward further growth.

“This facility in Canada is more than just a production site. Alongside the development and production of pioneering technology and bioreactors, we want to help other enterprises in the cellular agriculture and pharmaceutical industry flourish,” says Hamid R. Noori, Co-Founder and Co-CEO of The Cultivated B. “Our innovation hub, in particular, will help shape the landscape for cellular agriculture in the country and fill a major gap that we saw. We have aligned our goals with the government and Ontario Genomics, and I look forward to seeing how we will drive forward innovation and economic development together.”

“Canada, and specifically Ontario, has an opportunity to be at the forefront of a transformative industry. Our partnership with TCB will support biotechnology startups as they scale up their capacity to produce much needed foods, ingredients and materials,” says Bettina Hamelin, President and CEO, at Ontario Genomics. “There is undeniable growing consumer demand and huge industry momentum for these new and innovative products. This partnership is a critical next step for Canada to act on a window of opportunity to enhance resiliency in food supply chains while meeting common food security and sustainability goals.”

“Cells are essentially machines, and we are redesigning cells and plants to have them operate in the exact way we desire. Our new facility in Canada is a massive leap forward and a driving force behind this next industrial revolution,” says Raphael Heiner, Co-Founder and Co-CEO of The Cultivated B. “We are striving to use natural resources more efficiently, and our innovation hub will support other businesses working toward the same goal.”

Since 2019, Ontario Genomics has been driving the growth of the cellular agriculture community in Ontario and Canada. In November 2021, Ontario Genomics released the report Cellular Agriculture – Canada\’s $12.5 Billion Opportunity in Food Innovation, featuring extensive stakeholder input and economic analysis. The report found that the cellular agriculture industry is rapidly evolving and suggests a Canadian economic opportunity as high as $12.5 billion per year with the creation of up to 142,000 jobs. To achieve this, the country must develop a national vision and strategy for the Canadian cellular agriculture industry in the near term, establish a clear and transparent regulatory framework for cellular agriculture products in Canada, and provide supporting mechanisms for research and commercial development.

Following the report, in May 2022, Ontario Genomics and the Canadian Food Innovation Network (CFIN) announced more than $900K in funding for four cutting-edge cellular agriculture-focused food and beverage projects through their AcCELLerate-ON competition. AcCELLerate-ON is Canada’s first cellular agriculture-focused competition supporting the research and development of novel and innovative viable food production methods with the intent to drive economic growth and Ontario’s global leadership in this new and sustainable way to produce food. Ontario Genomics recently announced their new BioCreate program open to small- and medium-sized enterprises (SMEs) in southern Ontario seeking to commercialize genomics and engineering biology enabled products and/or technologies in the health, food and agriculture and cleantech sectors. Today’s announcement presents the next step to drive Ontario’s leadership in the cellular agriculture space, while creating the jobs, driving economic growth and the sustainable production of food and food ingredients for Ontario, and beyond.


Media Contact:
Polina Martins
Director of Communications and Public Affairs

Read The Cultivated B. news release.
Read the Toronto Global news release.

About The Cultivated B.
The Cultivated B. (TCB) is breaking new ground in the development of advanced biotechnology and bioengineering to enhance access to plant and cell-based alternative protein sources. TCB’s growing multinational team of scientists uses cellular agriculture, precision fermentation, and new approaches in bioreactor technology to drive forward the cultivated meat, food production, and personal care industries. By providing pioneering technology, TCB enriches the alternative protein and agritech industries and enables other companies to produce alternative proteins at an industrial scale. By utilizing TCB’s research and development capabilities, the parent company, InFamily Foods, will transform into a fully integrated food producer focusing on technology, innovation, and sustainable production serving future generations. With a fundamental commitment to minimizing the natural resources used, TCB is paving the way to a sustainable future locally, regionally, and globally.

About Ontario Genomics
Ontario Genomics is a not-for-profit organization funded by the Ontario government and Genome Canada and leading the application of genomics-based solutions to drive economic growth, improved quality of life and global leadership for Ontario. Ontario Genomics plays a vital role in advancing projects and programs by supporting the development of their proposals, helping them access diverse funding sources, and finding the right industry partners to take this research out of the lab to apply it to the world’s most pressing challenges. Since its inception in 2000, Ontario Genomics has raised more than $1.27 billion for genomics applied research in Ontario and directly supported more than 9,100 trainees and jobs. We have 110+ active projects, 500+ impactful partnerships and have secured $1.34 billion in follow-on investments.

About Toronto Global
Toronto Global’s team of experienced business advisors works to help international companies access the most dynamic and innovative region in the world. We actively seek global companies interested in expanding to the Toronto Region and connect investors with the right opportunities that will facilitate the successful growth of their business.
As an arms-length organization representing the Cities of Mississauga, Brampton and Toronto, and the Regional Municipalities of Durham, York, and Halton, we work with our partners in the Ontario and Canadian governments to provide a comprehensive, customized service that allows for a smooth transition for international companies wishing to do business here. Toronto Global is dedicated to understanding our clients’ business needs and delivering tailored, innovative solutions that will set the stage for their success in the Toronto Region.

Ontario Genomics and Government of Canada Announce BioCreate Program

Government of Canada invests over $5.6 million to help early-stage genomics companies bring new products to market

FedDev Ontario investment to support over 30 companies, create and maintain 160 jobs, and develop eight new products, services or processes, and over 32 new patents


October 21, 2022 – Toronto, Ontario – Federal Economic Development Agency for Southern Ontario (FedDev Ontario)

Research in genomics and engineering biology has led to the development of cutting-edge technologies and innovations in a number of important sectors, including public health, food, and the environment. By examining the genetic and environmental factors impacting the health of Canadians and understanding environmental changes, we can develop technologies and tools to address world challenges like disease and climate change, as well as to improve the health and well-being of Canadians.

Today, the Honourable Filomena Tassi, Minister responsible for the Federal Economic Development Agency for Southern Ontario (FedDev Ontario), announced an investment of over $5.6 million for Ontario Genomics to deliver the . The program will provide seed funding and support to help genomics SMEs in the health, food and agriculture, and cleantech sectors to bring new products and technologies to market.

Southern Ontario is recognized as a world leader in genomics and engineering biology research, but innovators often encounter challenges that prevent promising start-ups from scaling up and moving from research to commercialization. Through the BioCreate program, Ontario Genomics, in partnership with Velocity (Waterloo), McMaster Innovation Park/Synapse Life Sciences Consortium (Hamilton), Toronto Metropolitan University Science Discovery Zone (Toronto), and Cleantech Commons (Peterborough), will provide over 30 successful applicants with access to critical infrastructure including lab space, business support tools, mentoring, and tech development guidance.

Participating businesses are expected to create and maintain up to 160 highly skilled jobs, as well as create eight new products, services, or processes and more than 30 new patents. As well, approximately 25 percent of the firms participating in the program will be directed to an investment fund (The Firehood) that focuses on connecting women founders with mentors, partners and/or customers to help develop their business.

The Government of Canada is committed to supporting innovation in this important sector to help SMEs grow and commercialize technologies and improve the well-being of Canadians, create quality jobs, and boost Canada’s economy.


“Supporting Canadian innovators is a priority for the Government of Canada and today’s investment in Ontario Genomics and the BioCreate Program will provide Canadian genomics companies within the health, food and agriculture and cleantech sectors with access to the tools, mentorship and lab space they need for growth and success. This program will create 160 highly skilled jobs across Southern Ontario and help secure Canada’s place as a global leader in research and innovation.”
– The Honourable Filomena Tassi, Minister responsible for the Federal Economic Development Agency for Southern Ontario

“Ontario Genomics is helping to further develop a network in leading-edge innovation. This project will support the development of a healthy pipeline of high-potential start-up companies in health, agri-food and cleantech sectors, and create and maintain up to 160 highly skilled jobs across southern Ontario.”
– Bettina Hamelin, President and CEO Ontario Genomics

Quick Facts

  • Genomics is the study of all the genetic information of an organism’s genes.
  • Engineering (or synthetic) biology is a convergence of genomics and molecular biosciences with computing, automation, miniaturization, artificial intelligence (AI), and the application of engineering principles to biological systems.
  • Established in 2000, Ontario Genomics is a Toronto-based not-for-profit organization leading the application of genomics-based solutions across key sectors of the economy to drive economic growth, improved quality of life, and global leadership for Ontario.
  • Ontario Genomics has raised more than $1.27 billion for genomics research in Ontario and directly supported more than 9,100 jobs since 2000.
  • In 2021, the Government of Canada announced the development of at $400-million Pan-Canadian Genomics Strategy.
  • The Regional Innovation Ecosystem initiative, delivered by FedDev Ontario, aims to create, grow, and develop strong and inclusive regional ecosystems that support business growth and innovation, as well as the entrepreneurial environment necessary to foster more innovative regional economies and increase the competitiveness of SMEs.
  • Since November 2015, and throughout the pandemic, FedDev Ontario has invested more than $2.2 billion to support over 3,000 projects across southern Ontario, helping to create or maintain more than 180,000 jobs, and leveraging over $3.1 billion in additional investment in the region.

Associated Links

FedDev Ontario
Ontario Genomics


Edward Hutchinson
Press Secretary, Office of the Minister responsible for the Federal Economic Development Agency for Southern Ontario

FedDev Ontario Media Relations

Polina Martins
Director of Communications and Public Affairs, Ontario Genomics

Ontario Genomics Welcomes New Board Members

Ontario Genomics is pleased to announce the appointment of Alison Sunstrum and Nancy Carter to our Board of Directors. Two highly accomplished women in business, they bring a wealth of insight, experience, and expertise in areas crucial to our business and will contribute to achieving the of Ontario Genomics.

Nancy Carter is the Vice President, Legal and Corporate Governance of CANARIE Inc., a key partner in Canada’s National Research and Education Network. Nancy is responsible for legal matters, governance, risk management, compliance, and global projects, as well as aligning CANARIE’s equity, diversity, and inclusion goals with business outcomes. Nancy has been with the organization since 1997, and most recently served as CANARIE\’s Chief Financial Officer for 15 years. Nancy serves on the Board of Trustees of the American Registry for Internet Numbers (ARIN), chairing the Finance Committee, and is the former Treasurer of the Board of Directors for the Internet Society, Canada Chapter. Nancy has served on the CIRA NomCom, since 2018, acting as Chair since 2020. In addition, she has chaired the Steering Committee for the Canadian Internet Governance Forum since 2018.

Alison Sunstrum is Founder/CEO of CNSRV-X Inc. (Conserve X), a Canadian company researching and applying emerging technology in agriculture. Alison is a Venture Partner at Builders VC, a San Francisco/Calgary based venture capital fund investing in founders re-imagining large underinvested, antiquated industries. She is an investment committee member of The51. The51 is creating a critical mass of female-powered capital investing in women-led companies. Formerly as Co-CEO/Founder of GrowSafe Systems Ltd., she grew their research and development skunkworks from an Alberta garage to global operations receiving International recognition for science-based innovation. Alison holds patents for innovative technology and has presented widely on Big Data, the Internet of Livestock Things, and commercializing early-stage technology ventures. She is a member of the Agri-Food Innovation Council, the Canadian Council of Innovators, the Canadian Institute of Corporate Directors, and a former member of Canada’s economic strategy table. In 2021, she was named one of the “Top 50 In Canadian Agriculture”.

Ontario Genomics is also excited to announce that Dr. Ann Marie Vaughan will be stepping into the role of Vice-Chair of the Board and Chair of the Governance, Human Resources, and Nominations Committee. We thank Dr. Tom Corr for his service in the role of Vice-Chair and Chair of the Governance, Human Resources, and Nominations Committee.

Ontario Genomics thanks retiring board member, Dr. Alison Paprica, for her three years of expertise and service on our board and as a member of the Audit Committee.